Index | Ligand Name | Structure | PDB code | Compound Potency nM |
1 | tvu | BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1- thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2-carboxamide | 4uiu | 12.6 |
2 | 5u6 | Crystal structure of the BRD9 bromodamian in complex with BI-9564. | 5f1h | 14.1 |
3 | 5sw | CRYSTAL STRUCTURE OF BRD9 IN COMPLEX WITH BI-7273 | 5eu1 | 15.4 |
4 | xzb | BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | 4uiv | 15.8 |
5 | 5u2 | Crystal structure of the bromodomain of BRD9 in complex with compound 9. | 5f1l | 21 |
6 | bmf | Crystal structure of the bromodomain of human BRD9 in complex with bromosporine (BSP) | 5igm | 41.7 |
7 | h1b | BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | 4uiw | 50 |
8 | 69g | BRD9 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide) | 5i7y | 52 |
9 | n1d | BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one | 4uit | 200 |
10 | 5ty | Crystal structure of the BRD9 bromodomain in complex with compound 3. | 5f2p | 3.75e+004 |